High-risk pulmonary embolism (PE) also known as massive PE carries a high rate of
morbidity and mortality. The incidence of high-risk PE continues to increase, yet the …

Acute pulmonary embolism (PE) can present with non-specific signs and symptoms and thus
the diagnosis and management might not be as straightforward. This review outlines the …

Introduction and objectives This article presents the annual activity report of the
Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC) for the …

Study design The FlowTriever for Acute Massive pulmonary Embolism (FLAME) study was a
prospective cohort observational study designed to evaluate treatment outcomes in patients …

Introducción y objetivos Se presenta el informe de actividad del año 2022 de la Asociación
de Cardiología Intervencionista de la Sociedad Española de Cardiología (ACI-SEC) …

We are in a period of rapid evolution in the management of pulmonary embolism (PE).
However, morbidity and mortality related to PE remain high, and significant gaps persist in …

Recently, patients with out-of-hospital cardiac arrest (OHCA) refractory to conventional
resuscitation have started undergoing extracorporeal cardiopulmonary resuscitation …

Acute pulmonary embolism (PE) may manifest with mild nonspecific symptoms or progress
to a more severe hemodynamic collapse and sudden cardiac arrest. A substantial …

Background: For patients with high-risk pulmonary artery embolism (PE), catheter-directed
therapies pose a viable alternative treatment option to systemic thrombolysis or …

Purpose To evaluate effectiveness and safety of large-bore mechanical thrombectomy of
intermediate-or high-risk pulmonary embolism (PE) and factors associated with …